RecruitingNCT00178594
Evaluation of Hemostasis in Bleeding and Thrombotic Disorders
Evaluation of Hemostasis in Bleeding and Thrombotic Disorders Using the Roteg Analyzer and the Thrombin Generation Assay
Sponsor
The University of Texas Health Science Center, Houston
Enrollment
1,000 participants
Start Date
Oct 1, 2002
Study Type
OBSERVATIONAL
Conditions
Summary
The objective of this study will be to assess the coagulation system in-vitro in a variety of bleeding and clotting disorders using the ROTEG analyzer and the thrombin generation assay.
Eligibility
Min Age: 1 DayMax Age: 98 Years
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT00178594